Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Arthroscopic Broström repair with BioBrace augmentation for lateral ankle ligament injuries

Official title: Early Outcomes With and Without Use of a Novel Reinforced Bioinductive Implant in Arthroscopic Brostrom Repair: A Prospective Randomized Study

Run by Hancock Orthopedics · NCT07401095 · Data updated 2026-11-12

This trial will test whether adding the BioBrace implant to suture-anchor arthroscopic Broström repair helps adults with ATFL and lateral ankle instability recover better than suture anchors alone.

More Ankle Fractures trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorHancock Orthopedics
Academic / other
Locations1 site (Greenfield, Indiana)
StatusRecruiting
StartedDecember 8, 2025
Main results expectedJune 2028
Study endsDecember 2028
Registry record updatedFebruary 12, 2026
Trial IDNCT07401095 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) scheduled for a primary all-arthroscopic Broström repair who can consent and commit to scheduled follow-up visits are the intended participants.

Probably not a fit

Patients with prior Broström surgery, major additional ankle procedures, or medical or psychiatric conditions that affect recovery or follow-up are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, prospective randomized (1:1) trial enrolls adults undergoing primary all-arthroscopic Broström repair and randomizes them to standard suture-anchor repair or suture anchors plus the BioBrace implant. Clinical and patient-reported outcome measures for pain, function, activity, and safety are collected at baseline and at 1, 3, and 6 weeks, and at 3, 6, and 12 months postoperatively. The primary approach compares functional scores and complications between the two arms to see if augmentation improves recovery or reduces recurrence. Eligibility excludes prior Broström surgery, major concomitant procedures, or conditions that would alter recovery or impair consent or follow-up.

Why it matters

Potential benefit: If successful, BioBrace augmentation could reduce pain and instability and improve function or speed recovery after arthroscopic Broström repair.

How similar studies have gone: Small case series and nonrandomized reports have explored biologic or synthetic augmentation for lateral ankle repair, but high-quality randomized evidence on implants like BioBrace is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. At least 18 years of age at the time of surgery.
2. Able to read, understand and sign the informed consent form.
3. Willing to be available to attend each protocol required visit and complete the study required questionnaires.
4. Scheduled to undergo primary, arthroscopic Brostrom repair.

Exclusion Criteria:

1. Previous Brostrom surgery.
2. Concomitant procedures that would change the post operative course/recovery (i.e. total ankle replacement, OCD repair, foot/ankle osteotomies) as determined by the Investigator.
3. Currently participating or plans to enroll in another clinical trial during this study that would affect the outcomes of this study as determined by the Investigator.
4. History of non-compliance with medical treatment or clinical trial participation.
5. The subject is physically or mentally compromised (e.g., currently being treated for a psychiatric disorder, senile dementia, Alzheimer's disease, etc.), to the extent that the Investigator judges the subject to be unable or unlikely to remain compliant with protocol required follow-up.
6. Females of child-bearing potential who are either pregnant or breastfeeding or plan to become pregnant during the course of the study.
7. Any comorbidity or condition that renders the patient a poor surgical candidate as determined by the Investigator.
8. Hypersensitivity to any investigational device materials including collagen of animal origin (bovine type-I), poly-L-lactic acid (PLLA) or polyethylene glycol (PEG)

Where it's running

  • Hancock Orthopedics
    Greenfield, Indiana, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.